Office for Life Sciences Bulletin – 05 February 2021
OLS Introduction The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS). This bulletin aims to keep the life sciences sector up to date on the latest guidance and during the Coronavirus (COVID-19) outbreak, providing you with information from Government to help your members and networks prepare. If you would like to be added to the distribution list, please email nita.bhanot@beis.gov.uk For any questions on the UK/EU Trade and Cooperation Agreement please contact euexit@officeforlifesciences.gov.uk
News
NEW – On Monday 1 February, international trade secretary Liz Truss MP spoke to ministers in Japan and New Zealand to request to join the CPTPP, with formal negotiations to start this year. Joining the CPTPP would deepen the UK’s access to fast-growing markets and major economies, including Mexico, Malaysia and Vietnam, for the benefit of UK business. For further details, click here.
NEW - The Chancellor of the Duchy of Lancaster, Michael Gove, has written to Maroš Šefčovič, Vice President of the European Commission about the Northern Ireland Protocol. To read the letter, click here.
Regulation
NEW – Guidance has been published on Marketing Authorisation Application submission dates for 150-days national and European Commission decision reliance procedures. For more information, click here.
NEW – Guidance has been updated with a new recording of a webinar, which took place on 13 January 2021, on pharmacovigilance requirements for the UK authorised products. For more information, click here. UPDATED – Guidance on medical devices given exceptional use authorisations during the COVID-19 pandemic has been updated. For more information, click here.